chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had only experienced a short duration of minor pain and redness at injection site each time the vaccine was administered. I was pregnant during my last vaccination on 05/08/2008.  On 1/22/09 I delivered a son at 6 lb 8 oz.  On 1/23/09 Dr. discovered that my son had a right testicular torsion which occurred while in womb because the testicle was already considered dead and my son was not experiencing pain. My son's right testicle had to be removed and the left testicle was stitched into place to prevent  future twisting of the left testicle.   At the time of vaccination I was unaware I was pregnant. Dr. was not informed of this concern due to my pregnancy being transferred to another Dr.
Case number PHEH2014US025153, is an initial spontaneous report from a nurse received on 08 DEC 2014. This report refers to a 52 years old female patient. Historical conditions were not reported. No concomitant medications was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 22 OCT 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration (incorrect storage of drug).
pain is almost into his shoulder; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) and ARTHRALGIA (pain is almost into his shoulder) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ATENOLOL for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 10-Apr-2021, the patient experienced ARTHRALGIA (pain is almost into his shoulder). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 UNK and IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at a dose of 1 dosage form. On 06-Apr-2021, PAIN IN EXTREMITY (Arm pain) had resolved. At the time of the report, ARTHRALGIA (pain is almost into his shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Atenolol  is used as concomitant medication.  Tylenol and Advil were reported as treatment.
The patient experienced cold, clammy perspiration, became unconscious with rolling of eyes upward and petit mal seizures for a few seconds. The patient regained consciousness and was seen in the ER. The patient was diagnosed with syncope due to shots.
Very warm; arm was swollen; very red,; discomfort from the actual shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (discomfort from the actual shot), VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history provided).    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (discomfort from the actual shot). On 11-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,). On 04-Jan-2021, VACCINATION SITE DISCOMFORT (discomfort from the actual shot) had resolved. At the time of the report, VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment details included ice, antibiotics and Benadryl.
Rash / That is itchy; Arm was sore; red around injection site; This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 2nd dose of Shingrix (intramuscular). In October 2020, 1 week after receiving Shingrix, the patient experienced itchy rash, pain in arm and injection site erythema. On an unknown date, the outcome of the itchy rash and pain in arm were not recovered/not resolved and the outcome of the injection site erythema was recovered/resolved.   It was unknown if the reporter considered the itchy rash, pain in arm and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the 2nd dose of Shingrix 2 weeks ago.  The Patient reported the day after receiving the vaccine her arm was sore and red around the injection site and this lasted for about a week and then resolved. The patient reported that a week ago she developed a rash around the waistline that is itchy and still currently ongoing and spreading around the waist. Patient reported she has been using Cortisone 10 twice a day for the rash.
At injection site on right arm near shoulder at first my arm had a hard knot, very painful, intense burning and itching. for a couple months. Now for the last month where the knot was has caved in and feels mushy.  Shoulder and arm are stiff, very painful and still experiencing  burning and some itching. Since the vaccine I have had an on going headache that is constant and have been extremely tired to the point where I can't function.
Suspected vaccination failure; Three times after second vaccination/ Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles about five times).   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Three times after second vaccination/ Shingles). The patient was treated with gigartina skottsbergii (Red Marine Algae). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional Information: GSK receipt date: 03-Jul-2023 This case was reported the patient via interactive digital media. The patient had Shingles about five times. After the 2nd vaccination the patient experience three times. The patient started taking red marine algae on daily basis and it had returned. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up not possible as no contact details provided.
HANDS/ARMS/LEGS TREMORS, UNSTEADY GAIT, SPEECH IMPEDIMENT, FLATTENED AFFECT
Left arm pain; Body aches; Headaches; Fever; At the site of injection she had a rash, swelling and itching.; At the site of injection she had a rash, swelling and itching.; At the site of injection she had a rash, swelling and itching.; This is a spontaneous report from a contactable physician via a Pfizer sales representative.  A 67-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on 16Apr2019 at single dose for immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date, the patient experienced left arm pain, body aches, headaches, fever and at the site of injection she had a rash, swelling and itching. At the time of the report, the outcome of the events was unknown.  The information on the batch number has been requested.
PT LIED ON CONSENT FORM ABOUT DATE OF BIRTH SO WAS GIVEN THE VACCINE
After 5 minutes of receiving the vaccination, the patient complained of a warm, tingly sensation at the site of injection (normal reaction) but then added that her lips felt numb, which was puzzling to me. After consulting drug reference materials and the package insert, there was no mention of "numbing" sensations. It was possible that she was experiencing an allergic reaction so I sat with her and kept her talking to keep her relaxed and calm. I then asked her specific questions regarding the areas of affect including "Does it feel as though your tongue is swelling" and "Have you noticed a change in your heart rate or breathing pattern?" She answered no to both of those questions. I had her remain seated for approx. 30min following the vaccination to watch for signs of worsening symptoms or anaphylaxis to which there were none. I had the patient stand up and she said she felt fine except for local pain at the injection site (normal) and the numb lips (abnormal). I let her go home and told her that if anything changed or worsened that she needed to call me or her PCP. Around 4:30pm or so, she had contacted her PCP's office and talked with the Triage nurse who contacted me for more information. We then collaborated on possible reasons for her adverse reaction including her latex allergy (I wasn't using latex gloves and all of the materials used in the vaccination were all latex-free) but ruled everything else out except for a generally mild (but alarming to the patient) allergic reaction. The Triage nurse then told the patient to report to the ER should she find her symptoms worsening or anything else that felt abnormal. The Triage nurse was then going to contact the patient in the morning to follow up. The following morning (2/9/18), the patient reported that she was fine and that everything was normal again.
About 5 days after getting her Moderna Bivalent booster she had a seizer which started around 05:49am and lasted about an hour.  Lorazepam 2mg/ml gave 1ml initially. 0632 Dr. called for update on resident, notified that resident still seizing and that family declines wanting resident sent out to ER. Verbal order received to give repeat dose of lorazepam in 5 minutes if still seizing. 0637 second dose given. 0730 Family still declines wanting resident sent to ER; pupils fixed: BP 182/90, RR 26, AP 102, temp. 97.0. Right side of face drawn Dr. and ICP called. Morphine ordered. She was unresponsive from then on. She passed away on 12/02/2022 at 12:26pm.
Pt given vaccine at 17 years old and vaccine recommended for 18 years and older.
This spontaneous report as received from a nurse practitioner refers to a 10 month old patient. On 24-APR-2013 the patient was vaccinated with a third dose of ROTATEQ, 2 ml, orally. Nurse practitioner stated that the first dose of ROTATEQ (2 ml, oral) was given on 03-OCT-2012 and the second dose of ROTATEQ (2ml, oral) was given on 06-NOV-2012. No adverse effect reported. Additional information has been requested.
Patient complained of numbness and tingling in right hand radiating up to forearm Patient refused medical transport to hospital and signed AMA form
This spontaneous report as received from a nurse refers to a 7 months 29 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Starting 20 minutes after receiving the vaccine, I was leaving the vaccination site and my lips and tongue started tingling. It eventually progressed to them feeling numb. My throat felt like it was tightening up and my voice was getting raspy as if there was an obstruction. So, I pulled over in the closest parking lot and called my daughter who gave me information about a telehealth practice. I told her my location for safety in case it got worse. By the time I got through the queue of the telehealth practice, the symptoms had started to subside. They told me I should've called 911. The symptoms were similar to anaphylactic shock, but I did not want to call 911. By that point, the symptoms now had resolved but I had developed a headache (which I never get). When I got home, I took some Tylenol and the headache lasted for a few hours then resolved.
Progressive shortness of breath, developed hypoxia. Found to have pulmonary embolism in CT Angiogram. Treatment with EKOS catheter directed thrombolysis with tPA and anticoagulation
On 10/02/2009 Pt returned c/o (R) arm raised rash and (R) neck stiffness. Rash area was 100 mm below injection site, neck stiffness minimal.
5/7 PM: c/o sore throat 5/8: starting having tactile fever, chest pain, sweats, nausea 5/9: continued with above plus vomited once, dizzy, shaky, neck and back pain 5/10 and 5/11: same 5/12: fever to 103, went to the PMD and referred to the ER.
shingles; difficulty walking; foot on and off pain; bone is painful; left pelvic side on and off pain; nerves are painful; rashes on her butt not itchy at all and at the back of her knees as well; knee on and off pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful) and PELVIC PAIN (left pelvic side on and off pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gluten sensitivity, Seafood allergy (Allergic to Shrimp ) and Seafood allergy (Allergy to lobster).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful), PELVIC PAIN (left pelvic side on and off pain), NEURALGIA (nerves are painful), RASH (rashes on her butt not itchy at all and at the back of her knees as well) and ARTHRALGIA (knee on and off pain). The patient was treated with GABAPENTIN at an unspecified dose and frequency and PREDNISONE for Gluten sensitivity, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles), GAIT DISTURBANCE (difficulty walking), PAIN IN EXTREMITY (foot on and off pain), BONE PAIN (bone is painful), PELVIC PAIN (left pelvic side on and off pain), NEURALGIA (nerves are painful), RASH (rashes on her butt not itchy at all and at the back of her knees as well) and ARTHRALGIA (knee on and off pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: good (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's pain reportedly 8/10 on the pain scale sometimes and 6/10 most of the time. Patient could only walk on one side and couldn't really work for two weeks. Muscle relaxants did not help and events came back after Gabapentin medication wore off.  Patient underwent blood test (results not provided). Concomitant product use was not provided by the reporter.
01/25/2021-1/26/2021: photophobia, headache, general exhaustion, left shoulder discomfort 01/31/2021- dyspnea, tachypnea, palpitations, nausea, indigestion, dizziness, blurred vision, tremors/shaking 02/01/2021-on-going: dizziness and intermittent blurred vision and palpitations
At 48 hoursafter injection, the swollen area of neck is currently the size of an orange, making it painful and difficultto turn neck.; inexplicable, painful, noticeable swelling appeared on right hand side of neck, below the ear; experienced a numbness in left armfrom elbow to pinky; Pain in left arm around injection site; Headache occurred within 12 hours of injection and is starting to subside at 48 hours.; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0186) via an unspecified route of administration in the left arm on 24May2021 at 17:15(at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included cystic acne previously treated with accutane. The patient did not receive any medications within two weeks of vaccination. The patient previously received isotretinoin(ACCUTANE) from an unknown date for cystic acne. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 17:15 immediately following injection, the patient experienced a numbness in left arm that is the vaccination site arm from elbow to pinky, after 48 hours, numbness continues but was lessening. On 24May2021, the patient experienced pain in left arm around injection site, but was improving. On 24May2021 within 12 hours of injection, the patient experienced headache and started to subside at 48 hours. On 26May2021 at 05:15 roughly 36 hours after vaccination, the patient experienced inexplicable, painful, noticeable swelling appeared on right hand side of neck, below the ear. On 26May2021 at 15:15 at 48 hours after injection, the patient experienced the swollen area of neck was in the size of an orange, making it painful and difficult to turn neck. So the patient called nurseline with concern and determined to monitor for next 24 hours from home. The patient mentioned that he will schedule appointment if worsens or additional symptoms arise. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event headache and pain in left arm around injection site was recovering while that of numbness in left arm from elbow to pinky, inexplicable, painful, noticeable swelling appeared on right hand side of neck, below the ear and painful and difficult to turn neck were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
On 4/9, symptoms started as a body aches and low energy which lasted most of the day.  At around 7pm further symptoms began to develop and worsen. These included a fever, chills, headache, and shortness of breath which lasted until around 2am and then gave way to sweats.  In the morning of 4/10, symptoms had returned to only body aches and low energy which remained for the rest of the day. Symptoms seemed to have mostly diminished by midday 4/11.
Pt recvd 3 doses of Engerix-B & was reported as being a nonresponder; no antibody detected;
Covid-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Covid-19) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In March 2023, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown.            Concomitant product use was not provided by the reporter.  It was reported that patient did not had loss of taste.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-729732 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-729732:same reporter (Husband case)
Initial report received from healthcare professional on 06 Apr 2010: This patient received expired FLUVIRIN (batch no: 101328, exp. date: 31 Mar 2010), 0.5 ml intramuscular on 06 Apr 2010. No adverse event was noted after administration. Follow up report received from a physician on 18 May 2010: Patient demographics were added. The reporter stated that the patient received expired FLUVIRIN (batch no: 1013286P) 6 days after expiry date. No further information was provided.
Patient received COVID-19 on 5/1/2022. 5/4/2022, she noticed redness the size of a baseball and warmth to the reddened area (baseball-sized red, warm area to the site of injection). Cold compress applied.
Woke up to my teeth chattering and shaking do to freezing. The  chills lasted for four hours before I could get out of bed and take my temperature. My temperature  was 103.8 F.  On The 23rd  my temperature  remained between 102  and  103 with a severe headache. On today the 24th feeling better headache has subsided and temperature 99.2.
#2 Varicella injection given 9/13/11 in left upper arm. Pt received #1/2 on 8/15/11 w/o reaction. Presented with 10cm erythematous single welt like lesion positive tender. Local reaction vs cellulitis.
Pt recvd 2nd HIBTITER & leg which was injected turned dusky for a few seconds; apparently this also happened w/the 1st dose but was not observed by MD; resolved spontaneously;
Sore throat ~ 4 hours after vaccination followed by sore, red and watery eyes and cough. Development of periorbital edema. Lasted ~48 hours.
severe Asthma Attack, wheezing , shortness of breath, coughng chest pain extreme weakness / feeling like  i were  about to pass out  ended up in a steroid , used  my inhaler   and  utilized a nebulizer for  over a month
Information has been received from a nurse practitioner concerning a 16 year old female with a penicillin allergy who on 16 Nov 2006 was vaccainted with a first 0.5ml dose of HPV vaccine. Concomitant therapy included LOESTRIM. On 26 Nov 2006 the patient broke out into hives. The patient was treated with a steroid and was doing fine. No product quality complaint was involved. Additional information has been requested.
Received Janssen covid 19 vaccine 3/8/21 at 3PM. Twenty minutes after shot, felt skin flush pass over me and was directed to private area where paramedic took blood pressure and checked for hives. No hives but bumpy skin. Blood pressure spiked to 186/75. No history of such high blood pressure. Waited a while and blood pressure went down, flush and skin bumps subsided, and I went home. Blood pressure erratic in evening but never as high. Next day pulse higher than normal. Took homeopathic remedy. Pulse slowed down a bit. Better by next day.